Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bonneterre

Showing results (91-100 of 194) with videos related to

Pageof 20
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Prognostic value of p53 and urokinase-type plasminogen activator in node-negative human breast cancersJ P Peyrat, L Vanlemmens, J Fournier, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 1, 1993
Aminoglutethimide (AG) and hydrocortisone (HC) in bone metastases: a retrospective studyJ Bonneterre, A Adenis, J M Pion, et al.
Bulletin Du Cancer|July 27, 1999
[Advanced breast cancer: an evaluation of the cost of recurrence]C Bercez, T Lebrun, M E Bonneterre, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1997
Effectiveness of cold cap in the prevention of docetaxel-induced alopeciaM Lemenager, S Lecomte, M E Bonneterre, et al.
European Journal of Cancer (Oxford, England : 1990)|July 31, 2003
Anastrozole (Arimidex) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety resultsJ M Nabholtz, J Bonneterre, A Buzdar, et al.
British Journal of Cancer|August 26, 2010
Nasal septum perforation: a side effect of bevacizumab chemotherapy in breast cancer patientsA Mailliez, C Baldini, J T Van, et al.
Lille Medical : Journal De La Faculte De Medecine Et De Pharmacie De L'Universite De Lille|November 1, 1980
[Determination of cytosolic receptors for estradiol and progesterone in 137 cases of breast cancer: technics, clinical and histopathological correlations]D Dewailly, J Bonneterre, B Vandewalle, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Absence of germline mutations of exons 5 to 8 of the P53 gene in 26 breast cancer families from the north of FranceC Preudhomme, P Fenaux, J P Peyrat, et al.
European Journal of Cancer (Oxford, England : 1990)|October 15, 2003
Efficacy of tamoxifen following anastrozole ('Arimidex') compared with anastrozole following tamoxifen as first-line treatment for advanced breast cancer in postmenopausal womenB Thürlimann, J F R Robertson, J M Nabholtz, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|June 24, 2000
Germline BRCA1 mutations in patients from 84 families with breast and/or ovarian cancers in northern FranceJ P Peyrat, P Vennin, L Hornez, et al.
Pageof 20

Showing results (91-100 of 194) with videos related to

Sort By:
Pageof 20
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Prognostic value of p53 and urokinase-type plasminogen activator in node-negative human breast cancersJ P Peyrat, L Vanlemmens, J Fournier, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 1, 1993
Aminoglutethimide (AG) and hydrocortisone (HC) in bone metastases: a retrospective studyJ Bonneterre, A Adenis, J M Pion, et al.
Bulletin Du Cancer|July 27, 1999
[Advanced breast cancer: an evaluation of the cost of recurrence]C Bercez, T Lebrun, M E Bonneterre, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1997
Effectiveness of cold cap in the prevention of docetaxel-induced alopeciaM Lemenager, S Lecomte, M E Bonneterre, et al.
European Journal of Cancer (Oxford, England : 1990)|July 31, 2003
Anastrozole (Arimidex) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety resultsJ M Nabholtz, J Bonneterre, A Buzdar, et al.
British Journal of Cancer|August 26, 2010
Nasal septum perforation: a side effect of bevacizumab chemotherapy in breast cancer patientsA Mailliez, C Baldini, J T Van, et al.
Lille Medical : Journal De La Faculte De Medecine Et De Pharmacie De L'Universite De Lille|November 1, 1980
[Determination of cytosolic receptors for estradiol and progesterone in 137 cases of breast cancer: technics, clinical and histopathological correlations]D Dewailly, J Bonneterre, B Vandewalle, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Absence of germline mutations of exons 5 to 8 of the P53 gene in 26 breast cancer families from the north of FranceC Preudhomme, P Fenaux, J P Peyrat, et al.
European Journal of Cancer (Oxford, England : 1990)|October 15, 2003
Efficacy of tamoxifen following anastrozole ('Arimidex') compared with anastrozole following tamoxifen as first-line treatment for advanced breast cancer in postmenopausal womenB Thürlimann, J F R Robertson, J M Nabholtz, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|June 24, 2000
Germline BRCA1 mutations in patients from 84 families with breast and/or ovarian cancers in northern FranceJ P Peyrat, P Vennin, L Hornez, et al.
Pageof 20